Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: J Dev Behav Pediatr. 2021 Nov 23;43(5):283–290. doi: 10.1097/DBP.0000000000001041

Table 4.

Medication Use for PTSD and Control Youth

PTSD Control OR P value
n % with use n % with use
Antidepressant SSRI 294 30.79% 48 1.01% 21.28 0.000
Antidepressant SNRI 15 1.57% 0 0.00% NA NA
Antidepressant Other 120 12.57% 26 0.55% 8.55 0.000
Anti-Anxiety Other 54 5.65% 40 0.84% 2.83 0.002
Anticonvulsants 68 7.12% 26 0.55% 5.23 0.001
Antipsychotic 1st gen NA NA NA NA NA NA
Antipsychotic 2nd gen 162 16.96% 16 0.34% 30.14 0.000
Lithium NA NA NA NA NA NA
Sleep: Benzodiazepine 35 3.66% 26 0.55% 3.84 0.003
Sleep: Non-Benzodiazepine NA NA NA NA NA NA
Stimulants 149 15.60% 165 3.46% 3.23 0.008
ADHD: Other Medications 93 9.74% 26 0.55% 15.39 0.000